Market revenue in 2024 | USD 97.3 million |
Market revenue in 2030 | USD 148.0 million |
Growth rate | 7.2% (CAGR from 2025 to 2030) |
Largest segment | Reagents product |
Fastest growing segment | Others Product |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Instruments Product, Reagents Product, Others Product |
Key market players worldwide | Abbott Laboratories, Danaher Corp, BioMerieux SA, Roche Holding AG ADR, Bio-Rad Laboratories Inc, Agilent Technologies Inc, Becton Dickinson & Co, Hologic Inc, Illumina Inc, Grifols SA Ordinary Shares - Class A, Qiagen NV, Siemens Healthineers AG ADR, Sysmex Corp |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to infectious disease molecular diagnostics market will help companies and investors design strategic landscapes.
Reagents product was the largest segment with a revenue share of 67.63% in 2024. Horizon Databook has segmented the UAE infectious disease molecular diagnostics market based on instruments product, reagents product, others product covering the revenue growth of each sub-segment from 2018 to 2030.
The increasing incidence of infectious diseases is one of the major factors aiding overall market growth. According to the Gulf News, in 2017, around 20% of adults smoked in the country, and this is one of the biggest risk factors for infection of the respiratory tract.
As per CIA World Factbook’s observations, the prevalence of adult obesity in the UAE was 31.70%, and it ranks 20th in the world. In addition, the World Atlas states that obesity-related illnesses are a major economic burden on the country, which predisposes these individuals to infections, impelling market demand.
Increasing government healthcare investments is likely to fuel the market over the forecast period. For instance, in 2019, the government allocated a budget of USD 46 billion for healthcare, USD 540 million of which was granted for innovations in healthcare.
Horizon Databook provides a detailed overview of country-level data and insights on the UAE infectious disease molecular diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into UAE infectious disease molecular diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account